Literature DB >> 15600264

Homocysteine and vascular access thrombosis in a cohort of end-stage renal disease patients.

Rodney G Bowden1, Frank B Wyatt, Ronald Wilson, Collin Wilborn, Mindy Gentile.   

Abstract

BACKGROUND: Maintaining successful hemodialysis services is dependent upon an access to circulation that is reliable and stable. Complications of vascular access such as dysfunction, thrombosis, or infection are major causes of hospitalization with thrombosis being the most common reoccurring problem. Initial prospective evidence supports an independent association between total homocysteine (tHcy) levels and access thrombosis. The purpose of this study was to determine if significant associations exist between tHcy, age, gender, and vascular access thrombosis in patients with end-stage renal disease (ESRD). SUBJECTS AND METHODS: One hundred eighty-five (N=185) patients undergoing dialysis were selected as subjects. The retrospective sample was divided into a one or less vascular access thrombosis (VAT) (VAT) group (n= 133) and more than one (VAT II) VAT group (n= 52). The data was collected during a 16-month period (January 2000 to April 2002). Additional subgroup analyses included gender and age.
RESULTS: The Mann-Whitney U nonparametric t-Test for variance between groups revealed no significant difference in tHcy values between VAT groups (U=1841.50, p=0.284). A two-sample t-Test for variance between tHcy and age revealed no significant differences (F-ratio = 0.832, p = 0.32). A chi-square analysis revealed no significant differences in gender and VAT groups (chi2=0.246, p=0.62). A Kolmogorov-Smirnov test for normality was calculated for tHcy with a p-value of 0.859 revealing insufficient evidence that the distribution is not normal. Spearman Rank Correlations were calculated, revealing low to moderate associations among variables.
CONCLUSIONS: While some studies have demonstrated a relationship between tHcy and VAT, this study found that chronically high homocysteine levels in patients with ESRD were not associated with incidence of VAT. There were no significant differences in the number of VATs across additional variables of age and gender.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15600264     DOI: 10.1081/jdi-200037117

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  3 in total

1.  Relationship of MTHFR gene polymorphisms with renal and cardiac disease.

Authors:  Francesca M Trovato; Daniela Catalano; Angela Ragusa; G Fabio Martines; Clara Pirri; Maria Antonietta Buccheri; Concetta Di Nora; Guglielmo M Trovato
Journal:  World J Nephrol       Date:  2015-02-06

2.  5-methyltetrahydrofolate administration is associated with prolonged survival and reduced inflammation in ESRD patients.

Authors:  Giuseppe Cianciolo; Gaetano La Manna; Luigi Colì; Gabriele Donati; Francesca D'Addio; Elisa Persici; Giorgia Comai; Marylou Wratten; Ada Dormi; Vilma Mantovani; Gabriele Grossi; Sergio Stefoni
Journal:  Am J Nephrol       Date:  2008-06-30       Impact factor: 3.754

3.  Hyperhomocysteinemia and vascular access thrombosis in hemodialysis patients: a retrospective study.

Authors:  Chadi Saifan; Elie El-Charabaty; Suzanne El-Sayegh
Journal:  Vasc Health Risk Manag       Date:  2013-07-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.